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Introduction – Objectives
Colibacillosis is one of the leading causes of
disease-related economic loss in the poultry
sector
Colibacillosis is caused by an infection of avian
pathogenic Escherichia coli (APEC)
Fluoroquinolones, such as enrofloxacin
(ENRO) are frequently used antimicrobials (via
the drinking water) for the treatment of APEC
infections in the poultry industry
However, development and selection of
resistance to these antimicrobial drugs is an
increasing problem
The goal of this study was to assess the
prevalence and mechanisms of resistance
against ENRO in clinical APEC isolates from
Flanders.
 Determination of minimum inhibitory
concentration (MIC) distribution of 125
clinical APEC isolates (gradient strip test)
 Determination of mutant prevention
concentration (MPC) values of a sample of
sensitive strains, i.e. MIC values of 0.016
and 0.032 µg/mL (agar dilution technique)
 Non-wild type (NWT) strains were further
screened for the presence of QRDR
(quinolone resistance determining regions)
mutations (gyrA, ParC, ParE) and PMQR
(plasmid mediated quinolone resistance)
genes (qnrA, qnrB, qnrS, oqxAB, qepA)
using PCR, gel electrophoresis and gene
sequencing (Sanger)
Results: MIC and MPC
Figure (left). Enrofloxacin MIC distribution of the 125 avian
pathogenic Escherichia coli (APEC) strains isolated from broiler farms in
Flanders with colibacillosis outbreaks. The dotted line represents the
epidemiological cut-off (ECOFF), which is 0.125 µg/mL. Strains with MIC
values ≤ ECOFF are labelled wild type (WT, 60% of the strains) and
strains with higher MIC values than the ECOFF as non-wild type (NWT,
40% of the strains). The full lines marked CBS and CBD indicate the
clinical breakpoint for susceptibility (0.25 µg/mL, CBS) and resistance (2
µg/mL, CBR), respectively. Strains with MIC in between CBS and CBR are
designated intermediate (21% of the strains). Sixty-nine percent of the
strains were susceptible and 10% resistant.
Figure (right) . Enrofloxacin MPC distribution of
20 sensitive avian pathogenic Escherichia coli
(APEC) strains obtained via agar dilution
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Results: QRDR and PMQR
Table. Overview of the fluoroquinolone resistance
mechanisms (QRDR and PMQR) of the different NWT
strains (strains with MIC values above the ECOFF). Of all
the NWT strains (total 50) :
 92% carried one or more mutations in gyrA.
 ParC mutations occurred in 22% of the cases
 ParE mutations were rare (6% or 3 strains)
 18% possessed PMQR associated genes. Most
detected was qnrS (14%), followed by qnrB (4%). The
other investigated genes were not detected.
 MIC results: A large number of
strains (40%) were considered
NWT. In contrast to the relatively
high number of NWT strains, only
a minority of this group was
designated as resistant (R),





 MPC results: MPC values of the tested
isolates were fairly stable across the
different. In 76.67% of the cases, the
MPC was 0.125 µg/mL. Approximately
17% of the measurements had higher
MPC values. Two strains exhibited a
MPC/MIC ratio of 32 (MPC 0.5 and 1
µg/mL, respectively), indicating a large
mutant selection window (MSW). A
wide MSW increases the risk of
selective enrichment of resistant
subpopulations in a bacterial culture.
 QRDR/PMQR results: Chromosomal
mutations in DNA gyrase and
topoisomerase IV are the main source
of fluoroquinolone resistance in E. coli,
deemphasising the role of PMQR
mechanisms.
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